Abstract
In this issue of The Journal of Nuclear Medicine, Arulappu et al. present results of c-MET–specific peptide 18F-AH113804 PET screening for local regional recurrence after surgical excision of orthotopically implanted HCC1954 human basal-like breast cancer (BLBC) xenografts. 18F-AH113804 PET could
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
